Skip to main content

Sands Capital Ventures — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

99
Companies
$5.0B
Total invested
$53.0M
Avg. check
57
Industries
Health Care 11Artificial Intelligence (AI) 9Biotechnology 6Information Technology 5Software 4Medical Device 3+51 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 99
RayzeBio
September 2022

RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.

Biotechnology · San Diego$160.0M Series D
#Paid
August 2021

#Paid is a tech company that connects brands with influencers and content creators to develop and execute engaging social media campaigns.

Content Creators · Toronto$14.9M Series B
Klaviyo
August 2025

Klaviyo is an automation and email platform designed to help grow businesses.

Advertising · Boston$195.1M Post-IPO Secondary
Allotera Therapeutics
July 2026

Allotera Therapeutics is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

Biotechnology · St Louis$35.0M Series C
OneTrust
July 2023

OneTrust is the AI-Ready Governance platform helping organizations accelerate innovation while ensuring responsible data use.

Artificial Intelligence (AI) · Atlanta$150.0M Series D
Bluesight
July 2023

Bluesight is a medication intelligence company that utilizes AI and machine learning to reduce risks and solve supply chain inefficiencies.

Artificial Intelligence (AI) · AlexandriaPrivate Equity
LimaCharlie
July 2026

LimaCharlie is an Information security tools & infrastructure delivered in a manner similar to AWS.

Cloud Security · Covina$2.1M Debt Financing
Inspirna
July 2022

Inspirna is a biotechnology company developing drugs for the treatment of cancer.

Biotechnology · New York$55.1M Series D
Papercup
June 2022

Papercup translates videos using AI by generating voices that sound like the original speaker

Artificial Intelligence (AI) · London$20.0M Series A
Taysha Gene Therapies
June 2026

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

Biotechnology · Dallas$200.0M Post-IPO Equity
Luminoah
June 2023

Luminoah is a medical device company with a closed-loop personalized enteral nutrition platform to improve chronic disease care

Health Care · Charlottesville$6.0M Series A
Primer
June 2023

Primer develops a text analytics solution designed to automate the analysis of textual data.

Analytics · San Francisco$69.0M Series D
HUNGRY
June 2023

Hungry is a national food-tech platform that delivers happiness and wellbeing to the workplace.

Catering · Arlington$10.0M Series C
Exo
May 2025

Exo is a medical device startup which develops handheld ultrasound devices and AI for imaging and therapeutic applications.

Artificial Intelligence (AI) · Redwood CitySeries D
RevEng
May 2026

RevEng.ai is a deep AI framework for analysing binary computer programs.

Cyber Security · London$15.0M Series A
Redbud Brands
May 2022

Redbud Brands is a venture capital studio bringing people, ideas, and capital to create companies with an emphasis on the consumer space.

Brand Marketing · Austin$46.0M Venture - Series Unknown
Lyra Health
May 2026

Lyra helps companies improve access to effective mental health care for their employees.

Employee Benefits · California City$57.0M Series G
Acrivon Therapeutics
April 2024

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Biotechnology · Cambridge$130.0M Post-IPO Equity
ModMed
April 2025

Specialty-specific healthcare SaaS solutions including AI-Powered EHRs, Practice Management, Analytics, RCM, Patient Engagement, Payments

Artificial Intelligence (AI) · Boca Raton$100.0M Private Equity
Cnuic Technologies
April 2026

Cnuic Technologies has developed a working prototype of a completely new type of photolithography device.

Edinburgh$3.0M Pre-Seed
Spruce Biosciences
April 2026

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

Biopharma · South San Francisco$60.0M Post-IPO Equity
Keebler Health
April 2026

Keebler Health develops an AI-powered healthcare analytics platform focused on risk adjustment and clinical decision support.

Artificial Intelligence (AI) · Durham$16.0M Series A
CytoVale
April 2025

CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.

Artificial Intelligence (AI) · South San FranciscoVenture - Series Unknown
SafeRide Health
April 2025

SafeRide Health is a healthcare technology platform developer that aims to simplify medical services.

Health Care · Culver City$47.5M Debt Financing

Where Sands Capital Ventures invests

Health Care11
Artificial Intelligence (AI)9
Biotechnology6
Information Technology5
Software4
Medical Device3

About Sands Capital Ventures's portfolio

How many companies has Sands Capital Ventures invested in?

Sands Capital Ventures has invested in 99 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Sands Capital Ventures invest in?

Sands Capital Ventures's top investment sectors include Health Care, Artificial Intelligence (AI), Biotechnology, Information Technology, Software. The firm invests across 57 different industry categories.

What is Sands Capital Ventures's largest investment?

Among tracked funding rounds, Taysha Gene Therapies received $200.0M in a Post-IPO Equity round. Sands Capital Ventures's total known invested capital is $5.0B.

What is the average investment size for Sands Capital Ventures?

Sands Capital Ventures's average investment size is $53.0M across its portfolio of 99 companies.

What are Sands Capital Ventures's most recent investments?

Recent Sands Capital Ventures portfolio additions include RayzeBio, #Paid, Klaviyo, Allotera Therapeutics, OneTrust. These companies were founded in 2020 or later.

Reach the founders behind these 99 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →